Concepedia

Sherry Wang

SW

Statistics

Publications

12

Citations

1.4K

H-Index

12

Active since

2004

Affiliations

Pfizer (United States)(Current)

University of Colorado Denver

Massachusetts General Hospital

University of Pittsburgh Medical Center

University of California, Irvine

Sherry Wang is an author at Pfizer (United States) specializing in pharmacology, medicine, and molecular oncology.

ORCID

Publications per year

2004–2025

12

Publications

12

Does a stable isotopically labeled internal standard always correct analyte response?

Sherry Wang, Matthew J. Cyronak, Eric Yang · Journal of Pharmaceutical and Biomedical Analysis · 2006 · 397 citations

, , +9

Antitumor activity of crizotinib in lung cancers harboring a MET exon 14 alteration

Alexander Drilon, Jeffrey W. Clark, Jared Weiss et al. · Nature Medicine · 2020 · 393 citations · Full text

, , +12

Crizotinib in Patients With MET-Amplified NSCLC

D. Ross Camidge, Gregory A. Otterson, Jeffrey W. Clark et al. · Journal of Thoracic Oncology · 2021 · 168 citations · Full text

, , +17

Efficacy and safety of crizotinib in patients (pts) with advanced <i>MET</i> exon 14-altered non-small cell lung cancer (NSCLC).

Alexander Drilon, D. Ross Camidge, Sai‐Hong Ignatius Ou et al. · Journal of Clinical Oncology · 2016 · 111 citations

, , +14

Development of a highly sensitive and selective UPLC/MS/MS method for the simultaneous determination of testosterone and 5α-dihydrotestosterone in human serum to support testosterone replacement therapy for hypogonadism

Hermes Licea‐Perez, Sherry Wang, Matthew Szapacs et al. · Steroids · 2008 · 77 citations

, , +17

1–5 of 12